7
Total investments
1
Early stage
1
Mid stage
0
Late stage
14y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and advisor
2023
Tuune is a personalized womens healthcare company that is dedicated to improving the management of hormonal conditions for women. Specializing in building state-of-the-art clinical decision support software, Tuune firmly grounds its approach in clinical research, seamlessly integrating evidence-based health science into every aspect of care. Adopting a holistic approach, Tuune carefully evaluates up to 70 conditions, including mental health and cancer risks, to address the comprehensive well-being of each individual.
UK Board Member
Jan 2021
Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform.
We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives.
Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare.
For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.
Investor
2021
Lindus is an Accountable Research Organization, engineered to give biotech and pharmaceutical sponsors confidence and control to generate clinical data on time and on budget. In the last 3 years, Lindus has executed over 45 full-scope trials across cardiometabolic, respiratory, psychiatry, dermatology, womens health, and diagnostics. Behind each study is an integrated model spanning feasibility, central enrollment infrastructure, and flexible site models. Trials run on Citrus™, an AI-native trial operating system, and are governed by performance-based contracts with milestone-based payments. 82% of Lindus executed trials completed enrollment on or ahead of our proposed timeline. The company is backed by Dr. Bob Langer, Peter Thiel, and Dr. Tim Garnett.
Investor
2021
PocDoc is a digital health platform developed with the vision of allowing anyone with a smartphone or tablet to test themselves for a range of major diseases or conditions via a fingerprick of blood, receive a full health assessment that puts those results in context and then be offered solutions to address any health-related issues that arise.
The PocDoc platform has been designed to work with our proprietary, quantitative blood tests, which have been developed in-house and are focused on preventative disease areas (Cardiovascular Disease, Metabolic Disease and Renal Disease ). The platform can also integrate other existing rapid tests, digitise the results, and provide the same health assessment and follow-on care pathways.
PocDoc successfully rolled out the PocDoc Healthy Heart Check, which focuses on cardiovascular disease in homes, communities, healthcare organisations and pharmacies across the United Kingdom. PocDocs technology has been granted multiple patents worldwide and is set to be the first home testing diagnostic service to fully integrate with the NHS app.
Featured in the BBC News, BBC Breakfast News, The Daily Mail, The Telegraph and The Guardian.
PocDoc has won 3 Innovate UK awards and MedTech Breakthrough award for its technology.
For more information and to book a screening, visit www.pocdoc.co or follow us on Twitter / Facebook / Instagram on @mypocdoc
Board Member
Jan 2019
We deliver low-cost IG secure communication technology solutions proven to remove barriers between NHS healthcare professionals and improve patient care in the NHS. Used in Elective Care, Urgent Care, and Mental Health.
Fast to set up (some solutions within 72 hours) with no hardware integration or training required, all projects are fully managed by us.
Visit consultantconnect.org.uk for case studies and videos.
For more information call us on 01865 951 207 or email: info@consultantconnect.org.uk
Hear from NHS leaders, join our free webinars: consultantconnect.org.uk/webinars
Experience · 8 entries
All (8)
Investments (7)
Founder (1)
Board (3)
2024
2023
Investor and advisor
2023
Tuune is a personalized womens healthcare company that is dedicated to improving the management of hormonal conditions for women. Specializing in building state-of-the-art clinical decision support software, Tuune firmly grounds its approach in clinical research, seamlessly integrating evidence-based health science into every aspect of care. Adopting a holistic approach, Tuune carefully evaluates up to 70 conditions, including mental health and cancer risks, to address the comprehensive well-being of each individual.
2021
UK Board Member
Jan 2021
Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform.
We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives.
Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare.
For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.
Investor
2021
Lindus is an Accountable Research Organization, engineered to give biotech and pharmaceutical sponsors confidence and control to generate clinical data on time and on budget. In the last 3 years, Lindus has executed over 45 full-scope trials across cardiometabolic, respiratory, psychiatry, dermatology, womens health, and diagnostics. Behind each study is an integrated model spanning feasibility, central enrollment infrastructure, and flexible site models. Trials run on Citrus™, an AI-native trial operating system, and are governed by performance-based contracts with milestone-based payments. 82% of Lindus executed trials completed enrollment on or ahead of our proposed timeline. The company is backed by Dr. Bob Langer, Peter Thiel, and Dr. Tim Garnett.
Investor
2021
PocDoc is a digital health platform developed with the vision of allowing anyone with a smartphone or tablet to test themselves for a range of major diseases or conditions via a fingerprick of blood, receive a full health assessment that puts those results in context and then be offered solutions to address any health-related issues that arise.
The PocDoc platform has been designed to work with our proprietary, quantitative blood tests, which have been developed in-house and are focused on preventative disease areas (Cardiovascular Disease, Metabolic Disease and Renal Disease ). The platform can also integrate other existing rapid tests, digitise the results, and provide the same health assessment and follow-on care pathways.
PocDoc successfully rolled out the PocDoc Healthy Heart Check, which focuses on cardiovascular disease in homes, communities, healthcare organisations and pharmacies across the United Kingdom. PocDocs technology has been granted multiple patents worldwide and is set to be the first home testing diagnostic service to fully integrate with the NHS app.
Featured in the BBC News, BBC Breakfast News, The Daily Mail, The Telegraph and The Guardian.
PocDoc has won 3 Innovate UK awards and MedTech Breakthrough award for its technology.
For more information and to book a screening, visit www.pocdoc.co or follow us on Twitter / Facebook / Instagram on @mypocdoc
Show all 8 entries ↓
Investment activity
2012–2024 · 7 investments
Recent (last 2 years)Earlier
